In colorectal cancer, IL-22-producing infiltrating CD4 + and CD8 + T-cells were correlated with a better clinical outcome and increased infiltration of neutrophils, which in turn enhanced anti-tumor T-cell responses58. The gene discussed is CD8A; the disease is colorectal cancer.